Tectonic Therapeutic, Inc.
TECX
$15.64
$0.583.85%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 5.15M | 5.26M | 4.84M | 5.32M | 4.35M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 22.33M | 18.30M | 13.99M | 19.64M | 11.42M |
Operating Income | -22.33M | -18.30M | -13.99M | -19.64M | -11.42M |
Income Before Tax | -19.01M | -15.91M | -12.37M | -17.72M | -12.67M |
Income Tax Expenses | 976.00K | -- | -- | -- | -- |
Earnings from Continuing Operations | -19.98M | -15.91M | -12.37M | -17.72M | -12.67M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -19.98M | -15.91M | -12.37M | -17.72M | -12.67M |
EBIT | -22.33M | -18.30M | -13.99M | -19.64M | -11.42M |
EBITDA | -21.99M | -17.94M | -13.48M | -19.21M | -11.09M |
EPS Basic | -1.07 | -0.93 | -0.84 | -1.20 | -4.34 |
Normalized Basic EPS | -0.64 | -0.58 | -0.52 | -0.75 | -2.71 |
EPS Diluted | -1.07 | -0.93 | -0.84 | -1.20 | -4.34 |
Normalized Diluted EPS | -0.64 | -0.58 | -0.52 | -0.75 | -2.71 |
Average Basic Shares Outstanding | 18.68M | 17.16M | 14.79M | 14.73M | 2.92M |
Average Diluted Shares Outstanding | 18.68M | 17.16M | 14.79M | 14.73M | 2.92M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |